Parkinson’s disease polygenic risk prediction and haplotype analysis in a South American cohort
Objective: We aim to evaluate the performance of a Parkinson’s disease (PD) polygenic risk score (PRS), estimated using genome-wide association (GWAS) data from a European…TET2-mediated Cdkn2A DNA hydroxymethylation in dopaminergic neuronal injury of Parkinson’s disease
Objective: Studies have shown that 5-hmC modification is the reverse reaction of DNA methylation, and that this process is regulated by TET family hydroxylases, but…Profile of miRNA expression in CSF of Parkinson’s disease identifies miR-409-3p regulating the apoptosis of dopamine neurons
Objective: To improve the precise diagnosis of PD at early stage requires more feasible and objective methods. MicroRNA (miRNA) was believed to be a potential…Quantification of 123I-ioflupane Striatal Uptake and Individual Patient Diagnostic Predictions: Degenerative Parkinson’s disease, Non-Degenerative Parkinsonism and Tremor Disorders
Objective: To develop a fully automated quantitative method to analyse routinely acquired 123I-ioflupane (DaTSCAN) data to aid diagnostic predictions in patients with Parkinson’s disease, non-degenerative…Retinal Pathology in Parkinson’s Disease: A Longitudinal Study with Optical Coherence Tomography
Objective: The aim of this study was to find retinal pathology in Parkinson’s disease (PD) via Optical Coherence Tomography (OCT) that deteriorates over time, as…In vivo markers of anxiety in drug-naïve Parkinson’s disease
Objective: To investigate imaging and CSF markers of disease pathology associated with anxiety in drug-naïve idiopathic Parkinson’s disease (PD) patients. Background: Anxiety is a frequent…Subclinical cardiac autonomic dysfunction in patients with Parkinson’s disease: A pilot study
Objective: The aim of this study is to assess cardiac autonomic dysfunction in Parkinson’s disease (PD) patients. Background: Autonomic nervous system dysfunction (AD) is a…Long-term quality of life after subthalamic deep brain stimulation depends on non-motor symptoms in Parkinson’s disease
Objective: To predict 36-month follow-up quality of life (QoL) outcome after bilateral subthalamic nucleus deep brain stimulation (STN-DBS) in Parkinson’s disease (PD). Background: STN-DBS improves…Apathy as a non-motor symptom(NMS) in patients with Parkinson’s disease(PwPD) and patients with Huntington’s disease(PwHD) in Tomsk, Russia
Objective: The aim is to evaluate and compare the apathy profile in PwHD and PwPD, using the same clinical criteria to assess the severity of…Unmet psychological needs of People with Parkinson’s disease
Objective: To investigate whether Parkinson’s disease (PD) specialists are identifying patients with Parkinson’s psychological needs and referring them to appropriate services. Background: A number of…
- « Previous Page
- 1
- …
- 84
- 85
- 86
- 87
- 88
- …
- 388
- Next Page »